Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: Clarithromycin ,
Clofazimine ,
Rifabutin 💬 		--1件: 96 💬
2Biaxin ( clarithromycin)1件: Clarithromycin1件: Clarithromycin 💬 --1件: 299 💬
3Clarithromycin1件: Clarithromycin1件: Clarithromycin 💬 --8件: 6, 63, 84, 96, 97, 222, 228, 299 💬
4Clarithromycin (Not used as of 4/2020)1件: Clarithromycin1件: Clarithromycin 💬 --1件: 6 💬
5Lansoprazole, amoxicillin, clarithromycin3件: Amoxicillin (Aa-lansoprazole-amoxicillin-clarithromycin),
Clarithromycin,
Lansoprazole (Aa-lansoprazole-amoxicillin-clarithromycin)		4件: Amoxicillin ,
Clarithromycin ,
Lansoprazole ,
Amoxicillin 💬 		2件: ATP4A,
ATP4B 💬 		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 222 💬
6Lansoprazole, clarithromycin, amoxycillin3件: Amoxicillin (Aa-lansoprazole-amoxicillin-clarithromycin),
Clarithromycin,
Lansoprazole (Aa-lansoprazole-amoxicillin-clarithromycin)		4件: Amoxicillin ,
Clarithromycin ,
Lansoprazole ,
Amoxicillin 💬 		2件: ATP4A,
ATP4B 💬 		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 63 💬
7Rifabutin, Clarithromycin, and Clofazimine3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: Clarithromycin ,
Clofazimine ,
Rifabutin 💬 		--1件: 96 💬
8Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab tablets + amoxicillin + metronidazole (second-line eradication)3件: Amoxicillin (Aa-lansoprazole-amoxicillin-clarithromycin),
Clarithromycin,
Metronidazole		4件: Amoxicillin ,
Clarithromycin ,
Metronidazole ,
Amoxicillin 💬 		--1件: 63 💬